Mass spectrometric quantification of amino acid oxidation products identifies oxidative mechanisms of diabetic end-organ damage

Reviews in Endocrine and Metabolic Disorders

Volumn 9, Issue 4, 2008, Pages 275-287

  Vivekanadan Giri, Anuradha ^a   Wang, Jeffrey H ^a   Byun, Jaeman ^a   Pennathur, Subramaniam ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cardiovascular disease; Diabetic complications; Endothelial dysfunction; Gas chromatography mass spectrometry; High density lipoprotein; Low density lipoprotein; Oxidative stress; Oxidized amino acids

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINO ACID; CARBONYL DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLICLAZIDE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; MYELOPEROXIDASE; POLYUNSATURATED FATTY ACID; PRETERAX; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; UNCLASSIFIED DRUG; XANTHINE OXIDASE;

AMINO ACID BLOOD LEVEL; AMINO ACID OXIDATION; AMINO ACID URINE LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL PROLIFERATION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; ELECTRON TRANSPORT; ENDOTHELIAL DYSFUNCTION; GAS CHROMATOGRAPHY; GLUCOSE OXIDATION; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INSULIN TREATMENT; LIPID OXIDATION; MACROPHAGE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATION; OXIDATION KINETICS; OXIDATIVE STRESS; REVIEW;

AMINO ACIDS; ANIMALS; BLOOD GLUCOSE; DIABETES COMPLICATIONS; DIABETIC ANGIOPATHIES; ENDOTHELIUM; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LIPID METABOLISM; LIPOPROTEINS, HDL; MASS SPECTROMETRY; METABOLIC NETWORKS AND PATHWAYS; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE;

EID: 54949159132     PISSN: 13899155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11154-008-9093-1     Document Type: Review

References (107)

1. American Diabetes Association. Diabetes Statistics. http://www.diabetes. org/diabetes-statistics.jsp.
2. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053
3. PO Bonetti LO Lerman A Lerman 2003 Endothelial dysfunction: a marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 168 175
4. R Ross 1999 Atherosclerosis-an inflammatory disease N Engl J Med 340 115 126
5. Centers for Disease Control and Prevention. 2004. U.S Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta GA.
6. SM Haffner 2000 Coronary heart disease in patients with diabetes N Engl J Med 342 1040 1042
7. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234
8. FB Hu MJ Stampfer CG Solomon S Liu WC Willett FE Speizer 2001 The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up Arch Intern Med 161 1717 1723
9. EL Feldman 2003 Oxidative stress and diabetic neuropathy: a new understanding of an old problem J Clin Invest 111 431 433
10. DM Nathan 1998 Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study Lancet 352 832 833
11. R Klein BE Klien SE Moss 1989 The Wisconsin Epidemiologic Study of Diabetic Retinopathy: a review Diabetes Metab Rev 5 559 570
12. M Laakso 1999 Hyperglycemia and cardiovascular disease in type 2 diabetes Diabetes 48 937 942
13. CF Semenkovich JW Heinecke 1997 The mystery of diabetes and atherosclerosis: time for a new plot Diabetes 46 327 334
14. DCCT Research Group 1993 The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus N Engl J Med 329 977 986
15. UKPDS Research Group 1998 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 837 853
16. UKPDS Research Group 1998 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group Lancet 352 854 865
17. DCCT/EDIC Research Group 2000 Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group N Engl J Med 342 381 389
18. DM Nathan J Lachin P Cleary T Orchard DJ Brillon JY Backlund 2003 Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus N Engl J Med 348 2294 2303
19. The Action to Control Cardiovascular Risk in Diabetes Study Group 2008 Effects of intensive glucose lowering in type 2 diabetes N Engl J Med 358 2545 2559
20. The ADVANCE Collaborative Group 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572
21. RG Dluhy GT McMahon 2008 Intensive glycemic control in the ACCORD and ADVANCE trials N Engl J Med 358 2630 2633
22. JE Deanfield JP Halcox TJ Rabelink 2007 Endothelial function and dysfunction: testing and clinical relevance Circulation 115 1285 1295
23. C Rask-Madsen GL King 2007 Mechanisms of disease: endothelial dysfunction in insulin resistance and diabetes Nat Clin Pract Endocrinol Metab 3 46 56
24. M Brownlee 2001 Biochemistry and molecular cell biology of diabetic complications Nature 414 813 820
25. JW Baynes SR Thorpe 2000 Glycoxidation and lipoxidation in atherogenesis Free Radic Biol Med 28 1708 1716
26. S Pennathur JW Heinecke 2007 Mechanisms for oxidative stress in diabetic cardiovascular disease Antioxid Redox Signal 9 955 969
27. S Pennathur JW Heinecke 2007 Oxidative stress and endothelial dysfunction in vascular disease Curr Diab Rep 7 257 264
28. S Pennathur Y Ido JI Heller J Byun R Danda P Pergola 2005 Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes J Biol Chem 280 22706 22714
29. S Pennathur JD Wagner C Leeuwenburgh KN Litwak JW Heinecke 2001 A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease J Clin Invest 107 853 860
30. BN Ames MK Shigenaga TM Hagen 1993 Oxidants, antioxidants and the degenerative diseases of aging Proc Natl Acad Sci USA 90 7915 7922
31. M Brownlee 1995 Advanced protein glycosylation in diabetes and aging Annu Rev Med 46 223 234
32. JW Heinecke 2003 Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis Am J Cardiol 91 12A 16A
33. S Pennathur JW Heinecke 2004 Mechanisms of oxidative stress in diabetes: implications for the pathogenesis of vascular disease and antioxidant therapy Front Biosci 9 565 574
34. N Houstis ED Rosen ES Lander 2006 Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 944 948
35. JW Baynes SR Thorpe 1999 Role of oxidative stress in diabetic complications: a new perspective on an old paradigm Diabetes 48 1 9
36. JV Hunt RT Dean SP Wolff 1988 Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing Biochem J 256 205 212
37. M Brownlee A Cerami H Vlassara 1988 Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications N Engl J Med 318 1315 1321
38. TG Huggins MC Wells-Knecht NA Detorie JW Baynes SR Thorpe 1993 Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation J Biol Chem 268 12341 12347
39. TG Huggins MW Staton DG Dyer NJ Detorie MD Walla JW Baynes 1992 o-Tyrosine and dityrosine concentrations in oxidized proteins and lens proteins with age Ann N Y Acad Sci 663 436 437
40. H Kaur B Halliwell 1994 Detection of hydroxyl radicals by aromatic hydroxylation Methods Enzymol 233 67 82
41. HP Hammes X Du D Edelstein T Taguchi T Matsumura Q Ju 2003 Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy Nat Med 9 294 299
42. T Miyata Y Ueda A Yoshido S Sugiyama Y Iida M Jadoul 1997 Clearance of pentosidine, an advanced glycation end-product, by different modalities of renal replacement therapy Kidney Int 51 880 887
43. T Miyata C van Ypersele de Strihou K Kurokawa JW Baynes 1999 Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications Kidney Int 55 389 399
44. T Miyata MX Fu K Kurokawa C van Ypersele de Strihou SR Thorpe JW Baynes 1998 Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia? Kidney Int 54 1290 1295
45. DG Dyer JA Blackledge SR Thorpe JW Baynes 1991 Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo J Biol Chem 266 11654 11660
46. DR McCance DG Dyer JA Dunn KE Bailie SR Thorpe JW Baynes 1993 Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus J Clin Invest 91 2470 2478
47. VM Monnier 2001 Transition metals redox: reviving an old plot for diabetic vascular disease J Clin Invest 107 799 801
48. DR Sell A Lapolla P Odetti J Fogarty VM Monnier 1992 Pentosidine formation in skin correlates with the severity of complications in individuals with long-standing IDDM Diabetes 41 1286 1292
49. C Leeuwenburgh MM Hardy SL Hazen P Wagner S Oh-ishi UP Steinbrecher 1997 Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima J Biol Chem 272 1433 1436
50. S Pennathur C Bergt B Shao J Byun SY Kassim P Singh 2004 Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species J Biol Chem 279 42977 42983
51. MH Shishehbor RJ Aviles ML Brennan X Fu M Goormastic GL Pearce 2003 Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy JAMA 289 1675 1680
52. MH Shishehbor ML Brennan RJ Aviles X Fu MS Penn DL Sprecher 2003 Statins promote potent systemic antioxidant effects through specific inflammatory pathways Circulation 108 426 431
53. JP Eiserich M Hristova CE Cross AD Jones BA Freeman B Halliwell 1998 Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils Nature 391 393 397
54. SJ Klebanoff 1980 Oxygen metabolism and the toxic properties of phagocytes Ann Intern Med 93 480 489
55. Klebanoff SJ, Clark RA. The neutrophil: function and clinical disorders. Amsterdam: North Holland; 1978. p. 447-51.
56. JP Gaut J Byun HD Tran WM Lauber JA Carroll RS Hotchkiss 2002 Myeloperoxidase produces nitrating oxidants in vivo J Clin Invest 109 1311 1319
57. R Zhang ML Brennan X Fu RJ Aviles GL Pearce MS Penn 2001 Association between myeloperoxidase levels and risk of coronary artery disease JAMA 286 2136 2142
58. S Sugiyama Y Okada GK Sukhova R Virmani JW Heinecke P Libby 2001 Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes Am J Pathol 158 879 891
59. ML Brennan MS Penn F Van Lente V Nambi MH Shishehbor RJ Aviles 2003 Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 1595 1604
60. C Bergt S Pennathur X Fu J Byun K O'Brien TO McDonald 2004 The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc Natl Acad Sci USA 101 13032 13037
61. SL Hazen JW Heinecke 1997 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Invest 99 2075 2081
62. H Cai 2005 NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease Circ Res 96 818 822
63. Heart Outcomes Prevention Evaluation Study Investigators 2000 Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy Lancet 355 253 259
64. TJ Guzik J Sadowski B Guzik A Jopek B Kapelak P Przybylowski 2006 Coronary artery superoxide production and nox isoform expression in human coronary artery disease Arterioscler Thromb Vasc Biol 26 333 339
65. Y Gorin K Block J Hernandez B Bhandari B Wagner JL Barnes 2005 Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney J Biol Chem 280 39616 29626
66. U Landmesser S Dikalov SR Price L McCann T Fukai SM Holland 2003 Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension J Clin Invest 111 1201 1209
67. J Vasquez-Vivar B Kalyanaraman P Martasek N Hogg BS Masters H Karoui 1998 Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors Proc Natl Acad Sci USA 95 9220 9225
68. TJ Guzik DG Harrison 2006 Vascular NADPH oxidases as drug targets for novel antioxidant strategies Drug Discov Today 11 524 533
69. JW Knowles RL Reddick JC Jennette EG Shesely O Smithies N Maeda 2000 Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment J Clin Invest 105 451 458
70. PJ Kuhlencordt R Gyurko F Han M Scherrer-Crosbie TH Aretz R Hajjar 2001 Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice Circulation 104 448 454
71. T Takaya K Hirata T Yamashita M Shinohara N Sasaki N Inoue 2007 A specific role for eNOS-derived reactive oxygen species in atherosclerosis progression Arterioscler Thromb Vasc Biol 27 1632 1637
72. T Nakagawa W Sato O Glushakova M Heinig T Clarke M Campbell-Thompson 2007 Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy J Am Soc Nephrol 18 539 550
73. HJ Zhao S Wang H Cheng MZ Zhang T Takahashi AB Fogo 2006 Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice J Am Soc Nephrol 17 2664 2669
74. U Landmesser S Spiekermann C Preuss S Sorrentino D Fischer C Manes 2007 Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease Arterioscler Thromb Vasc Biol 27 943 948
75. R Bucala Z Makita T Koschinsky A Cerami H Vlassara 1993 Lipid advanced glycosylation: pathway for lipid oxidation in vivo Proc Natl Acad Sci USA 90 6434 6438
76. R Bucala Z Makita G Vega S Grundy T Koschinsky A Cerami 1994 Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency Proc Natl Acad Sci USA 91 9441 9445
77. JV Hunt CC Smith SP Wolf 1990 Oxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose Diabetes 39 1420 1424
78. M Kawamura JW Heinecke A Chait 1994 Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway J Clin Invest 94 771 778
79. MX Fu JR Requena AJ Jenkins TJ Lyons JW Baynes SR Thorpe 1996 The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions J Biol Chem 271 9982 9986
80. JR Requena MU Ahmed CW Fountain TP Degenhardt S Reddy C Perez 1997 Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo J Biol Chem 272 17473 17479
81. JR Requena MX Fu MU Ahmed AJ Jenkins TJ Lyons JW Baynes 1997 Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein Biochem J 322 Pt 1 317 325
82. JR Requena MX Fu MU Ahmed AJ Jenkins TJ Lyons SR Thorpe 1996 Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions Nephrol Dial Transplant 11 Suppl 5 48 53
83. A Mezzetti F Cipollone F Cuccurullo 2000 Oxidative stress and cardiovascular complications of diabetes: isoprostanes as new markers on an old paradigm Cardiovasc Res 47 475 488
84. G Davi G Ciabattoni A Consoli A Mezzetti A Falco S Santarone 1999 In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation Circulation 99 224 229
85. JM Onorato AJ Jenkins SR Thorpe JW Baynes 2000 Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine J Biol Chem 275 21177 21184
86. PA Voziyan TO Metz JW Baynes BG Hudson 2002 A post-Amadori inhibitor pyridoxamine also inhibits chemical modification of proteins by scavenging carbonyl intermediates of carbohydrate and lipid degradation J Biol Chem 277 3397 3403
87. M Brownlee H Vlassara A Kooney P Ulrich A Cerami 1986 Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking Science 232 1629 1632
88. D Edelstein M Brownlee 1992 Aminoguanidine ameliorates albuminuria in diabetic hypertensive rats Diabetologia 35 96 97
89. HP Hammes S Martin K Federlin K Geisen M Brownlee 1991 Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy Proc Natl Acad Sci USA 88 11555 11558
90. HP Hammes M Brownlee D Edelstein M Saleck S Martin K Federlin 1994 Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat Diabetologia 37 32 35
91. S Ihm J Hyung S Park J Ihm 1999 Effect of aminoguanidine on lipid-peroxidation in streptozotocin-induced diabetic rats Metabolism 48 1141 1145
92. A Stitt TA Gardiner NL Alderson P Canning N Frizzell N Duffy 2002 The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes Diabetes 51 2826 2832
93. TP Degenhardt NL Alderson DD Arrington RJ Beattie JM Basgen MW Steffes 2002 Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat Kidney Int 61 939 950
94. S Bhattacharjee S Pennathur J Byun J Crowley D Mueller J Gischler 2001 NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation Arch Biochem Biophys 395 69 77
95. ML Brennan SL Hazen 2003 Amino acid and protein oxidation in cardiovascular disease Amino Acids 25 365 374
96. SL Hazen JR Crowley DM Mueller JW Heinecke 1997 Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation Free Radic Biol Med 23 909 916
97. N Lamharzi CB Renard F Kramer S Pennathur JW Heinecke A Chait 2004 Hyperlipidemia in concert with hyperglycemia stimulates the proliferation of macrophages in atherosclerotic lesions: potential role of glucose-oxidized LDL Diabetes 53 3217 3225
98. C Leeuwenburgh P Hansen A Shaish JO Holloszy JW Heinecke 1998 Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats Am J Physiol 274 R453 R461
99. C Leeuwenburgh PA Hansen JO Holloszy JW Heinecke 1999 Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine Free Radic Biol Med 27 186 192
100. C Leeuwenburgh PA Hansen JO Holloszy JW Heinecke 1999 Oxidized amino acids in the urine of aging rats: potential markers for assessing oxidative stress in vivo Am J Physiol 276 R128 R135
101. C Leeuwenburgh JE Rasmussen FF Hsu DM Mueller S Pennathur JW Heinecke 1997 Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques J Biol Chem 272 3520 3526
102. C Leeuwenburgh P Wagner JO Holloszy RS Sohal JW Heinecke 1997 Caloric restriction attenuates dityrosine cross-linking of cardiac and skeletal muscle proteins in aging mice Arch Biochem Biophys 346 74 80
103. S Pennathur V Jackson-Lewis S Przedborski JW Heinecke 1999 Mass spectrometric quantification of 3-nitrotyrosine, ortho-tyrosine, and o,o′-dityrosine in brain tissue of 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated mice, a model of oxidative stress in Parkinson's disease J Biol Chem 274 34621 3468
104. L Zheng B Nukuna ML Brennan M Sun M Goormastic M Settle 2004 Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J Clin Invest 114 529 541
105. M Lorenzi C Gerhardinger 2001 Early cellular and molecular changes induced by diabetes in the retina Diabetologia 44 791 804
106. SX Zhang J Sima C Shao J Fant Y Chen B Rohrer 2004 Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes Diabetologia 47 124 131
107. MH Shishehbor SL Hazen 2004 Inflammatory and oxidative markers in atherosclerosis: relationship to outcome Curr Atheroscler Rep 6 243 250